Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Molecular Integration of Incretin and Glucocorticoid Action Reverses Immunometabolic Dysfunction and Obesity.

Cell metabolism | 2017

Chronic inflammation has been proposed to contribute to the pathogenesis of diet-induced obesity. However, scarce therapeutic options are available to treat obesity and the associated immunometabolic complications. Glucocorticoids are routinely employed for the management of inflammatory diseases, but their pleiotropic nature leads to detrimental metabolic side effects. We developed a glucagon-like peptide-1 (GLP-1)-dexamethasone co-agonist in which GLP-1 selectively delivers dexamethasone to GLP-1 receptor-expressing cells. GLP-1-dexamethasone lowers body weight up to 25% in obese mice by targeting the hypothalamic control of feeding and by increasing energy expenditure. This strategy reverses hypothalamic and systemic inflammation while improving glucose tolerance and insulin sensitivity. The selective preference for GLP-1 receptor bypasses deleterious effects of dexamethasone on glucose handling, bone integrity, and hypothalamus-pituitary-adrenal axis activity. Thus, GLP-1-directed glucocorticoid pharmacology represents a safe and efficacious therapy option for diet-induced immunometabolic derangements and the resulting obesity.

Pubmed ID: 28943448 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Somatostatin (D-20) (antibody)

RRID:AB_2302603

This polyclonal targets SST

View all literature mentions

Insulin (C27C9) Rabbit mAb (antibody)

RRID:AB_2126503

This monoclonal targets Insulin (C27C9) Rabbit mAb

View all literature mentions

Proopiomelanocortin Precursor (POMC) (27-52) (antibody)

RRID:AB_2307442

This polyclonal targets Aminoacids 27-52 of porcine Pro-opiomelanocortin peptide

View all literature mentions

Anti-IBA 1 (antibody)

RRID:AB_10641962

This polyclonal targets IBA 1

View all literature mentions

HEK293 (cell line)

RRID:CVCL_0045

Cell line HEK293 is a Transformed cell line with a species of origin Homo sapiens (Human)

View all literature mentions

GraphPad Prism (software resource)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

B6.Cg-Lepob/J (organism)

RRID:IMSR_JAX:000632

Mus musculus with name B6.Cg-Lepob/J from IMSR.

View all literature mentions

B6.Cg-Tg(Ins1-cre/ERT)1Lphi/J (organism)

RRID:IMSR_JAX:024709

Mus musculus with name B6.Cg-Tg(Ins1-cre/ERT)1Lphi/J from IMSR.

View all literature mentions

B6.Cg-Tg(Nes-cre)1Kln/J (organism)

RRID:IMSR_JAX:003771

Mus musculus with name B6.Cg-Tg(Nes-cre)1Kln/J from IMSR.

View all literature mentions

C57BL/6J (organism)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions